Following Debiopharm’s decision to rely on AlpVision anti-counterfeiting solutions to protect their products against counterfeits, which was reported back in January 2011, two other main pharmaceutical producers of branded medicines have signed licences for roll-out of AlpVision’s covert digital solutions for product authentication. The worldwide deployment will take place in the course of 2011.

This confirms AlpVision as a leading provider of the pharmaceutical industry, helping branded product manufacturers to combat counterfeiting and to uncover market diversion and other frauds.